Advisory Research Inc Deciphera Pharmaceuticals, Inc. Transaction History

Advisory Research Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$43.8 - $58.16 $679,031 - $901,654	-15,503 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$37.05 - $65.03 $52,425 - $92,017	-1,415 Reduced 8.36%	15,503 $926,000
Q1 2020 May 12, 2020	BUY	$33.63 - $69.4 $251,586 - $519,181	7,481 Added 79.27%	16,918 $697,000
Q4 2019 Feb 11, 2020	BUY	$31.7 - $69.93 $299,152 - $659,929	9,437 New	9,437 $587,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.